Leukemia & Lymphoma
Volume 60, 2019 - Issue 9
Original Articles
Impact of early rasburicase on incidence of clinical tumor lysis syndrome in lymphoma
Heather A. PersonettDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA; Correspondence[email protected]
http://orcid.org/0000-0001-5704-2867View further author information
http://orcid.org/0000-0001-5704-2867View further author information, Erin F. BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA; ;Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; http://orcid.org/0000-0002-0996-1487View further author information
http://orcid.org/0000-0002-0996-1487View further author information, Kristen B. McCulloughDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USA; http://orcid.org/0000-0003-4252-2619View further author information
http://orcid.org/0000-0003-4252-2619View further author information, , Nelson LeungDivision of Nephrology and Hypertension and Division of Hematology, Mayo Clinic, Rochester, MN, USA; ;Division of Hematology, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0002-5651-1411View further author information
http://orcid.org/0000-0002-5651-1411View further author information & 